Fig. 1: Expression of MBD2 and its clinical significance in lung adenocarcinoma patients. | Cell Death & Disease

Fig. 1: Expression of MBD2 and its clinical significance in lung adenocarcinoma patients.

From: MBD2 facilitates tumor metastasis by mitigating DDB2 expression

Fig. 1: Expression of MBD2 and its clinical significance in lung adenocarcinoma patients.The alternative text for this image may have been generated using AI.

A The mRNA level of MBD2 was compared between 69 pairs of lung adenocarcinoma tissue samples (LUAD) and adjacent nontumor tissue samples (Normal). The expression of MBD2 was associated with sex (B), smoking history (C), degree of tumor differentiation (D), tumor stage (E), N stage (F), and M stage (G) in lung adenocarcinoma patients (n = 69). H Survival curves for MBD2 high group and MBD2 low group (The cutoff value is 15.02, n = 269). The data were originated from the Human Protein Atlas database. Each dot expresses one patient sample. N node, M metastasis. The data are presented as the mean ± SD. *p < 0.05.

Back to article page